Literature DB >> 2970594

Transfer of a functional human immune system to mice with severe combined immunodeficiency.

D E Mosier1, R J Gulizia, S M Baird, D B Wilson.   

Abstract

The pressing need for a better experimental system for AIDS research has brought into sharp focus the shortcomings of available animal models and the practical and ethical limitations of studies of immune responses and viral pathogenesis in humans. Current studies of the human immune responses are limited to relatively restrictive in vivo experiments and several in vitro systems that, although useful, allow only short-term studies and support responses to a few antigens. Neither model is particularly amenable to studies of the pathogenesis of diseases of the immune system. We report here that injection of human peripheral blood leukocytes (PBL) can result in the stable long-term reconstitution of a functional human immune system in mice with severe combined immunodeficiency (SCID). Human PBL transplanted to SCID mice increase in number and survive for at least six months; reconstituted mice show spontaneous secretion of human immunoglobulin and a specific human antibody response is induced following immunization with tetanus toxoid. All of the major cell populations present in PBL are found in the lymphoid tissue and blood of SCID recipients, although the relative proportions of B cells, T-cell subsets and monocytes/macrophages in long-term recipients differ from those found in normal PBL and, in mice transplanted with 50 x 10(6) or more PBL from Epstein-Barr virus (EBV)-seropositive donors, EBV-positive B-cell lymphomas often develop. Our results suggest that xenogeneic transplantation of human lymphoid cells into SCID mice may provide a useful model for the study of normal human immune function, the response of the immune system to pathogenic agents and early events in lymphomagensis.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2970594     DOI: 10.1038/335256a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  320 in total

Review 1.  Characterization of the human antiporcine immune response: a prerequisite to xenotransplantation.

Authors:  A L Bothwell
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

2.  Immunohistochemical analysis, human papillomavirus DNA detection, hormonal manipulation, and exogenous gene expression of normal and dysplastic human cervical epithelium in severe combined immunodeficiency mice.

Authors:  J A Taylor; K Tewari; S Y Liao; C C Hughes; L P Villarreal
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

Review 3.  Are natural killer cells the key to treating Epstein-Barr virus-associated lymphoproliferative disorders?

Authors:  M J Robertson
Journal:  J Clin Invest       Date:  2001-09       Impact factor: 14.808

4.  Experimental infection of severe combined immunodeficient beige mice with Mycobacterium paratuberculosis of bovine origin.

Authors:  G K Mutwiri; D G Butler; S Rosendal; J Yager
Journal:  Infect Immun       Date:  1992-10       Impact factor: 3.441

Review 5.  SCID mice in the study of human autoimmune diseases.

Authors:  M A Duchosal
Journal:  Springer Semin Immunopathol       Date:  1992

Review 6.  HIV-1 immunopathogenesis in humanized mouse models.

Authors:  Liguo Zhang; Lishan Su
Journal:  Cell Mol Immunol       Date:  2012-04-16       Impact factor: 11.530

Review 7.  Use of nonobese diabetic mice to understand human type 1 diabetes.

Authors:  Terri C Thayer; S Brian Wilson; Clayton E Mathews
Journal:  Endocrinol Metab Clin North Am       Date:  2010-07-08       Impact factor: 4.741

8.  Factors affecting human T cell engraftment, trafficking, and associated xenogeneic graft-vs-host disease in NOD/SCID beta2mnull mice.

Authors:  Bruno Nervi; Michael P Rettig; Julie K Ritchey; Hanlin L Wang; Gerhard Bauer; Jon Walker; Mark L Bonyhadi; Ronald J Berenson; Julie L Prior; David Piwnica-Worms; Jan A Nolta; John F DiPersio
Journal:  Exp Hematol       Date:  2007-08-30       Impact factor: 3.084

9.  Protective immune responses induced by secretion of a chimeric soluble protein from a recombinant Mycobacterium bovis bacillus Calmette-Guérin vector candidate vaccine for human immunodeficiency virus type 1 in small animals.

Authors:  M Honda; K Matsuo; T Nakasone; Y Okamoto; H Yoshizaki; K Kitamura; W Sugiura; K Watanabe; Y Fukushima; S Haga; Y Katsura; H Tasaka; K Komuro; T Yamada; T Asano; A Yamazaki; S Yamazaki
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-07       Impact factor: 11.205

10.  Human prolactin promotes human secondary immunoglobulin response in human/SCID mouse chimeras.

Authors:  Jian Zhang; Rui Sun; Zhigang Tian
Journal:  Clin Vaccine Immunol       Date:  2006-11-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.